Gnothisafton

Is INO the next short squeeze case?

Long
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
INO, with its strong upward move yesterday, crossed over both the 30d (9.75) and the 50d (10.48) SMA and closed at $10.58.

The next very important resistance is at 13.80 (200d SMA). The large divergence of the RSI and the oversold level of the MACD indicate
that the upward movement will continue. Any price retreat will be a buying opportunity.

Inovio Pharmaceuticals with a sort interest of 33.80% is one of the most shorted stocks (No 25) so a short squeeze is very likely to take place in the very next days.

Disclaimer
The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.